Related content

Preoperative BRAF(V600E) mutation screening is unlikely to alter initial surgical treatment of patients with indeterminate thyroid nodules: A prospective case series of 960 patients

By Lodewijk Lutske   Kist Jakob W.   Valk Gerlof D.   Vriens Menno R.   Borel Rinkes Inne H.M.  

Cancer, Vol. 120, Iss. 7, 2014-04 ,pp. : 1083-1084

Blackwell Publishing

Access to resources Recommend Favorite

Helix-Coil Transition Signatures B-Raf V600E Mutation and Virtual Screening for Inhibitors Directed Against Mutant B-Raf

By  

Current Drug Metabolism, Vol. 18, Iss. 6, 2017-07 ,pp. : 527-534

Bentham Science Publishers

Access to resources Recommend Favorite

The use of BRAF V600E mutation‐specific immunohistochemistry in pediatric Langerhans cell histiocytosis

By  

Hematological Oncology (Electronic), Vol. 36, Iss. 1, 2018-02 ,pp. : 307-315

John Wiley & Sons Inc

Access to resources Recommend Favorite

Acute renal failure associated with the new BRAF inhibitor vemurafenib: A case series of 8 patients

By Launay-Vacher Vincent   Zimner-Rapuch Sarah   Poulalhon Nicolas   Fraisse Thibault   Garrigue Valérie   Gosselin Morgane   Amet Sabine   Janus Nicolas   Deray Gilbert  

Cancer, Vol. 120, Iss. 14, 2014-07 ,pp. : 2158-2163

Blackwell Publishing

Access to resources Recommend Favorite

Prediction of Activities of BRAF (V600E) Inhibitors by SW-MLR and GA-MLR Methods

By  

Current Computer - Aided Drug Design, Vol. 13, Iss. 3, 2017-07 ,pp. : 249-261

Bentham Science Publishers

Access to resources Recommend Favorite